title: Letter to the Editor in reply to Dayyani and Morgenstern's comment on the article "Identifying risk in the use of tumor markers to improve patient safety".
authors.forename: Elvira Eva
authors.initials: EE
authors.lastname: Moreno-Campoy
authors.forename: Francisco J
authors.identifier: 0000-0002-1545-3665
authors.initials: FJ
authors.lastname: Mérida-De la Torre
authors.forename: Francisco
authors.identifier: 0000-0003-4585-5195
authors.initials: F
authors.lastname: Martos-Crespo
authors.forename: Mario
authors.identifier: 0000-0002-0270-1711
authors.initials: M
authors.lastname: Plebani
mesh_terms: D014408:Biomarkers, Tumor; D006801:Humans; D061214:Patient Safety; D018570:Risk Assessment
chemical_list: D014408:Biomarkers, Tumor